Researchers formulate single dose intranasal vaccine for measles, mumps, multiple COVID variants
A team of researchers formulated a trivalent intranasal vaccine known as MMS, which protects against measles, mumps, and various SARS-CoV-2 variants.
A team of researchers formulated a trivalent intranasal vaccine known as MMS, which protects against measles, mumps, and various SARS-CoV-2 variants.